Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway

Neuroscience Letters

Volumn 416, Issue 3, 2007, Pages 299-301

  Haugarvoll, Kristoffer ^a,b   Toft, Mathias ^a,b   Ross, Owen A ^a   White, Linda R ^b   Aasly, Jan O ^b,c   Farrer, Matthew J ^a  

^a MAYO CLINIC   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Genetics; LRRK1; LRRK2; Norway; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 1; LEUCINE RICH REPEAT KINASE 2; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; HUMANS; LYSINE; MALE; MIDDLE AGED; NORWAY; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 33947585082     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.02.020     Document Type: Article

References (12)

1. Aasly J.O., Toft M., Fernandez-Mata I., Kachergus J., Hulihan M., White L.R., and Farrer M. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann. Neurol. 57 (2005) 762-765
2. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
3. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 7 (2006) 306-318
4. Farrer M.J., Stone J.T., Lin C.H., Dachsel J.C., Hulihan M.M., Haugarvoll K., Ross O.A., and Wu R.M. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat. Disord. (2007)
5. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 56 (1999) 33-39
6. Haugarvoll K., and Wszolek Z.K. PARK8 LRRK2 parkinsonism. Curr. Neurol. Neurosci. Rep. 6 (2006) 287-294
7. Korr D., Toschi L., Donner P., Pohlenz H.D., Kreft B., and Weiss B. LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal. 18 (2006) 910-920
8. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., and Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
9. Marin I. The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol. Biol. Evol. 23 (2006) 2423-2433
10. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero£ I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., and St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
11. Taylor J.P., Hulihan M.M., Kachergus J.M., Melrose H.L., Lincoln S.J., Hinkle K.M., Stone J.T., Ross O.A., Hauser R., Aasly J., Gasser T., Payami H., Wszolek Z.K., and Farrer M.J. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics (2007)
12. West A.B., Moore D.J., Choi C., Andrabi S.A., Li X., Dikeman D., Biskup S., Zhang Z., Lim K.L., Dawson V.L., and Dawson T.M. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16 (2007) 223-232